ESC 365 - Relationship between hypoglycaemia, outcomes and empagliflozin treatment effect in EMPA-REG OUTCOME

ESC Premium Access

Relationship between hypoglycaemia, outcomes and empagliflozin treatment effect in EMPA-REG OUTCOME

Session: Late Breaking Science in Cardiovascular Pharmacology

Topic: Antidiabetic Pharmacotherapy

Speaker: Doctor D. Fitchett (Toronto, CA)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor David Fitchett

St. Michael's Hospital, Toronto (Canada)

18 presentations

0 follower

4 more presentations in this session

International Registry of Anakinra for Pericarditis

Speaker: Professor M. Imazio (Udine, IT)

A risk based approach to the role of aspirin on cardiovascular risk reduction in a healthy older cohort

Speaker: Professor C. Reid (Melbourne, AU)

Effects of omega-3 fatty acid supplements on arrhythmias in the ASCEND study

Speaker: Professor S. Parish (Oxford, GB)

Combination of low dose rivaroxaban and aspirin in females and males with chronic coronary artery disease or peripheral artery disease

Speaker: Doctor Y. Liang (Beijing, CN)

Access the full session

Late Breaking Science in Cardiovascular Pharmacology

Speakers: Doctor D. Fitchett, Professor M. Imazio, Professor C. Reid, Professor S. Parish, Doctor Y. Liang

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources